Biogen to Initiate Phase 4 Study Evaluating Benefit of Spinraza® in Patients Treated With Zolgensma®

21 July 2020 / Posted in: Treatments & Research

Biogen have announced today that it plans to initiate this clinical study, called RESPOND, to examine the clinical benefit, and assess the safety, of Spinraza in infants and children who have SMA, who still have unmet clinical needs following treatment with the gene therapy treatment Zolgensma.

Read full story

Changing Places Compulsory for New Buildings in England from 2021

20 July 2020 / Posted in: Information, Support

Shopping centres, supermarkets, sports and arts venues will be required to include at least one Changing Place. There was also further funding announced for more Changing Places toilets at service stations in England.

Read full story

Face Masks for Children who have a Rare Condition

20 July 2020 / Posted in: Information, Support

The not-for-profit arts organisation Same But Different are giving these away free for children in the UK who have a rare condition.

Read full story

Impact of COVID-19 on Physical Activity and Wellbeing in Adults who have a Neurologically-Related Mobility Disability

16 July 2020 / Posted in: Information, Support

The University of Birmingham is running this survey to find about more about the impact that the pandemic has had on physical activity and health-related quality of life.

Read full story

Our Thanks to our Retiring Trustees

16 July 2020 / Posted in: Information

Our July board meeting saw a number of changes to the composition of our Board of Trustees, including 3 members stepping down - we'd like to thank them for their tireless and dedicated support, their advocacy for our cause, as well as their wisdom and counsel.

Read full story

NICE to discuss Zolgensma at 8th October Committee meeting

14 July 2020 / Posted in: Treatments & Research

Onasemnogene abeparvovec (Zolgensma) has been rescheduled into the National Institute for Health and Care Excellence’s (NICE’s) work programme and is due to be discussed at committee on this date

Read full story

European consensus statement concerning treatment with Zolgensma

13 July 2020 / Posted in: Treatments & Research

A group of prominent European neuromuscular experts have provided eleven consensus statements covering many aspects of treatment with onasemnogene abeparvovec (Zolgensma).

Read full story

Effect of risdiplam on Female Fertility and Menstruation

10 July 2020 / Posted in: Treatments & Research

Roche has responded to the question we asked on behalf of the Community about this.

Read full story

Further Small Studies Support the Use of Nusinersen for SMA Treatment in Adults

03 July 2020 / Posted in: Treatments & Research

Three scientific reports have been published that present observations from adults who have SMA treated with repeated injections of nusinersen into the fluid bathing the spinal cord and brain.

Read full story

Over 150 Organisations Call on Government to Prioritise Children as Much as Health and the Economy

30 June 2020 / Posted in: Information, Support

The impact of the COVID-19 pandemic has been widespread, affecting everybody in the country, and, in particular, this generation of children face unprecedented threats to their childhoods and life chances. They deserve an unprecedented response.

Read full story